首页>
外国专利>
USE OF C4BP-ALPHA PROTEIN IN HUMAN SERUM TO PREDICT CLOPIDOGREL RESISTANCE AND ITS CLINICAL APPLICATION AS A NOVEL BIOMARKER
USE OF C4BP-ALPHA PROTEIN IN HUMAN SERUM TO PREDICT CLOPIDOGREL RESISTANCE AND ITS CLINICAL APPLICATION AS A NOVEL BIOMARKER
展开▼
机译:C4BP-α蛋白在人血清中用于预测卵磷脂抵抗力的研究及其作为新型生物标志物的临床应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention discloses a novel biomarker for predicting clopidogrel resistance and a clinical application thereof. Application of C4BPα protein in human serum as an assay target or standard substance in the preparation of an assay kit for predicting clopidogrel resistance is disclosed. Clinically, the detection of C4BPα in human serum can predict clopidogrel resistance, thereby providing a novel assay for guiding rational use of clopidogrel or drug switching, and helping clinicians to diagnose or predict the clinical efficacy of clopidogrel.
展开▼